Prevalence and associates of metabolic syndrome among adult residents in Yunnan province, 2021
-
摘要:
目的 了解云南省成年居民代谢综合征(MS)的患病现状及其影响因素,为采取有针对性的MS防控及干预措施提供参考依据。 方法 于2021年1 — 12月采用多阶段分层随机抽样方法在云南省8个县(区)抽取9600名 ≥ 18岁成年常住居民进行问卷调查、体格检查和实验室检测。 结果 云南省有效调查的7396名成年居民中,MS患者1210例,MS患病率为16.4%;多因素非条件logistic回归分析结果显示,年龄 ≥ 35岁、有高血压家族史和体质指数(BMI) ≥ 24.0是云南省成年居民MS患病的危险因素,女性是云南省成年居民MS患病的保护因素;MS不同异常组分聚集模式中,云南省成年居民最常见的代谢异常组合为“中心性肥胖 + 血压异常 + 高甘油三酯(TG)”,为397例,患病率为5.37%。 结论 云南省成年居民MS患病率较高,中老年男性、超重肥胖和有高血压家族史居民为该地区MS防控的重点人群。 Abstract:Objective To investigate the prevalence of metabolic syndrome (MS) and its associated factors among adult residents in Yunnan province, and to provide a reference for the adoption of targeted MS prevention and control measures. Methods Face-to-face interview with a questionnaire developed by National Center for Cardiovascular Diseases, physical examination and laboratory tests were conducted among 9 600 adult permanent residents ( ≥ 18 years of age) recruited in 8 counties (districts) of Yunnan province with stratified multistage random sampling during 2021. Results Of the 7 396 participants surveyed effectively, 1 210 (16.4%) were assessed as suffering from MS. Multivariate logistic regression analysis showed that age ≥ 35 years old, family history of hypertension and with a body mass index (BMI) of ≥ 24.0 were risk factors for MS; while, female gender was a protective factor for MS. Among different aggregation patterns for abnormal components of MS, the most common combination of metabolic abnormalities detected among the participants was “abdominal obesity + elevated blood pressure + high triglycerides”. Conclusion MS is prevalent seriously among adult residents in Yunnan province. Middle-aged and elderly men, persons being overweight or obese, and people with family history of hypertension should be considered as high-risk groups in MS prevention and control. -
Key words:
- metabolic syndrome /
- prevalence /
- influencing factor /
- adult residents
-
表 1 云南省不同特征成年居民MS患病情况比较
特征 调查人数 MS患病例数 MS患病率(%) χ2 值 P 值 性别 男性 3612 735 20.3 82.081 < 0.001 女性 3784 475 12.6 年龄(岁) 18~34 2543 168 6.6 324.632 a < 0.001 35~44 1472 230 15.6 45~54 1271 262 20.6 55~64 883 217 24.6 ≥ 65 1227 333 27.1 民族 汉族 5072 836 16.5 0.177 0.674 少数民族 2324 374 16.1 文化程度 小学及以下 2458 556 22.6 105.427 < 0.001 初中及以上 4938 654 13.2 人均可支配收入(万元) ≤ 3 4793 821 17.1 5.885 0.015 > 3 2603 389 14.9 居住地 城市 4000 685 17.1 3.724 0.054 农村 3396 525 15.5 吸烟情况 不吸烟 5552 854 15.4 15.577 < 0.001 吸烟 1844 356 19.3 饮酒情况 不饮酒 6200 954 15.4 26.532 <0.001 饮酒 1196 256 21.4 体力活动情况 不足 4367 725 16.6 0.455 0.500 充足 3029 485 16.0 有无高血压家族史b 无 4873 701 14.4 27.883 < 0.001 有 2089 406 19.4 有无糖尿病家族史b 无 6558 1024 15.6 9.353 0.002 有 424 90 21.2 BMI < 24.0 4014 159 4.0 1374.078 < 0.001 24.0~27.9 2385 548 23.0 ≥ 28.0 997 503 50.5 注:a 采用趋势性χ2检验;b 数据有缺失。 表 2 云南省成年居民MS患病影响因素多因素非条件logistic回归分析
因素 参照组 比较组 β $S_{\bar x}$ Wald χ2 值 P 值 OR 值 95%CI 性别 女性 男性 − 0.655 0.078 71.160 < 0.001 0.520 0.446~0.605 年龄(岁) 35~44 18~34 0.683 0.120 32.359 < 0.001 1.981 1.565~2.506 45~54 1.032 0.120 73.421 < 0.001 2.807 2.217~3.554 55~64 1.439 0.130 122.887 < 0.001 4.215 3.268~5.435 ≥ 65 1.854 0.124 223.226 < 0.001 6.386 5.008~8.145 有无高血压家族史 有 无 0.285 0.082 11.899 0.001 1.329 1.131~1.562 BMI 24.0~27.9 < 24.0 1.908 0.104 338.185 < 0.001 6.738 5.499~8.258 ≥ 28.0 3.304 0.114 842.757 < 0.001 27.208 21.769~34.006 表 3 云南省成年居民MS不同异常组分聚集模式
MS组合
种类(种)中心性
肥胖血压
异常血糖
异常高TG 低HDL-C 患病数 患病率(%) 3 + + + – – 105 1.42 3 + + – + – 397 5.37 3 + + – – + 43 0.58 3 – + + + – 126 1.70 3 – + + – + 19 0.26 3 – – + + + 18 0.24 3 + – + – + 11 0.15 3 + – – + + 39 0.53 3 – + – + + 79 1.07 3 + – + + – 19 0.26 4 + + + – + 17 0.23 4 + – + + + 18 0.24 4 – + + + + 58 0.78 4 + + – + + 72 0.97 4 + + + + – 130 1.76 5 + + + + + 59 0.80 注:“ + ”表示存在该项代谢异常组分,“–”表示不存在该项代谢异常组分。 -
[1] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志, 2018, 10(1): 4 – 67. doi: 10.3760/cma.j.issn.1674-5809.2018.01.003 [2] O'Neill S, O'Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies[J]. Obesity Reviews, 2015, 16(1): 1 – 12. doi: 10.1111/obr.12229 [3] 杨舒越, 李松涛, 应旭华, 等. 浙江省海岛农村社区成年人代谢综合征发病率及其危险因素[J]. 中华流行病学杂志, 2022, 43(3): 387 – 391. doi: 10.3760/cma.j.cn112338-20210305-00175 [4] Li YR, Zhao LY, Yu DM, et al. Metabolic syndrome preva-lence and its risk factors among adults in China: a nationally representative cross - sectional study[J]. PLoS One, 2018, 13(6): e0199293. doi: 10.1371/journal.pone.0199293 [5] Yao F, Bo YC, Zhao LY, et al. Prevalence and influencing factors of metabolic syndrome among adults in China from 2015 to 2017[J]. Nutrients, 2021, 13(12): 4475. doi: 10.3390/nu13124475 [6] Wu LT, Shen YF, Hu L, et al. Prevalence and associated factors of metabolic syndrome in adults: a population - based epidemiological survey in Jiangxi province, China[J]. BMC Public Health, 2020, 20(1): 133. doi: 10.1186/s12889-020-8207-x [7] 中华人民共和国民政部. 行政区划代码[EB/OL]. [2022 – 05 – 23]. http://www.mca.gov.cn/article/sj/xzqh/1980/?. [8] Li GJ, Wang HL, Wang K, et al. The association between smoking and blood pressure in men: a cross - sectional study[J]. BMC Public Health, 2017, 17(1): 797. doi: 10.1186/s12889-017-4802-x [9] 陈璐, 潘烺, 刘秋萍, 等. 2008 — 2018年北京城区某健康体检人群饮酒行为变化趋势[J]. 中华疾病控制杂志, 2021, 25(3): 284 – 288. [10] Bull FC, Al-Ansari SS, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour[J]. British Journal of Sports Medicine, 2020, 54(24): 1451 – 1462. doi: 10.1136/bjsports-2020-102955 [11] Liu Q, Li YX, Hu ZH, et al. Comparing associations of different metabolic syndrome definitions with ischemic stroke in Chinese elderly population[J]. European Journal of Internal Medicine, 2018, 47: 75 – 81. doi: 10.1016/j.ejim.2017.10.010 [12] Hess PL, Al-Khalidi HR, Friedman DJ, et al. The metabolic syndrome and risk of sudden cardiac death: the atherosclerosis risk in communities study[J]. Journal of the American Heart Associa-tion, 2017, 6(8): e006103. doi: 10.1161/JAHA.117.006103 [13] Guembe MJ, Fernandez-Lazaro CI, Sayon-Orea C, et al. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13 - year prospective study in the RIVANA cohort[J]. Cardiovascular Diabetology, 2020, 19(1): 195. doi: 10.1186/s12933-020-01166-6 [14] 李望. 成都市中老年人代谢综合征患病情况及其危险因素分析[J]. 中国公共卫生, 2021, 37(1): 40 – 43. [15] 程冷眉, 朱丽萍, 颜玮, 等. 江西省成年居民代谢综合征患病及影响因素分析[J]. 中国公共卫生, 2017, 33(5): 751 – 754. doi: 10.11847/zgggws2017-33-05-17 [16] 洪汝丹, 陆林, 杨永芳, 等. 云南省6县(区)常住居民代谢综合征患病率及其影响因素分析[J]. 中国慢性病预防与控制, 2013, 21(5): 530 – 535. doi: 10.16386/j.cjpccd.issn.1004-6194.2013.05.028 [17] 刘建勋, 李建彬, 祁辉, 等. 郑州市成人代谢综合征流行现状及其影响因素[J]. 中华健康管理学杂志, 2020, 14(4): 361 – 364. doi: 10.3760/cma.j.cn115624-20200331-00250 [18] 赵晶晶, 曹亚景, 孙纪新, 等. 河北省成人代谢综合征的流行及相关因素分析[J]. 现代预防医学, 2021, 48(23): 4370 – 4376. [19] 段晓阳, 李敏, 祁志刚, 等. 高血压家族史和行为危险因素聚集与高血压患病关系[J]. 中国公共卫生, 2022, 38(2): 172 – 176. doi: 10.11847/zgggws1135107 [20] Wang YF, Zhao L, Gao LW, et al. Health policy and public health implications of obesity in China[J]. The Lancet Diabetes and Endocrinology, 2021, 9(7): 446 – 461. doi: 10.1016/S2213-8587(21)00118-2 [21] 国家心血管病中心. 中国心血管健康与疾病报告2019[M]. 北京: 科学出版社, 2020. [22] 戴璟, 闵杰青, 杨云娟. 中国九省市成年人血脂异常流行特点研究[J]. 中华心血管病杂志, 2018, 46(2): 114 – 118. [23] 中国胆固醇教育计划委员会. 高甘油三酯血症及其心血管风险管理专家共识[J]. 中华心血管病杂志, 2017, 45(2): 108 – 115. [24] Zhang FF, Liu LL, Zhang CD, et al. Association of metabolic syndrome and its components with risk of stroke recurrence and mortality: a meta - analysis[J]. Neurology, 2021, 97(7): e695 – e705. doi: 10.1212/WNL.0000000000012415 -

计量
- 文章访问数: 67
- HTML全文浏览量: 20
- PDF下载量: 24
- 被引次数: 0